Skip to main content

Cookies on GOV.UK

We use some essential cookies to make this website work.

We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.

We also use cookies set by other sites to help us deliver content from their services.

View cookies

You can change your cookie settings at any time.

GOV.UK

Navigation menu

  • Topics

    Find information and services

    • Benefits
    • Births, death, marriages and care
    • Business and self-employed
    • Childcare and parenting
    • Citizenship and living in the UK
    • Crime, justice and the law
    • Disabled people
    • Driving and transport
    • Education and learning
    • Employing people
    • Environment and countryside
    • Housing and local services
    • Money and tax
    • Passports, travel and living abroad
    • Visas and immigration
    • Working, jobs and pensions
  • Government activity

    Search for a department and find out what the government is doing

    • Departments

      Departments, agencies and public bodies

    • News

      News stories, speeches, letters and notices

    • Guidance and regulation

      Detailed guidance, regulations and rules

    • Research and statistics

      Reports, analysis and official statistics

    • Policy papers and consultations

      Consultations and strategy

    • Transparency

      Data, Freedom of Information releases and corporate reports


    • How government works
    • Get involved

Search

Search GOV.UK

Popular on GOV.UK

  • Moving to the UK from Ukraine
  • Coronavirus (COVID-19)
  • Find a job
  • Personal tax account: sign in
  • Universal Credit account: sign in
  1. Home
  2. Medicines and Healthcare products Regulatory Agency
Medicines and Healthcare products Regulatory Agency

Services and information

Blood regulation and safety

  • Medical devices: how to comply with the legal requirements in Great Britain
  • MHRA fees
  • Blood: authorisations and safety reporting
  • Make a payment to MHRA
  • See more

Clinical trials and investigations

  • Clinical trials for medicines: apply for authorisation in the UK
  • Clinical trials for medicines: manage your authorisation, report safety issues
  • Oral COVID-19 antiviral, Paxlovid, approved by UK regulator
  • Notify the MHRA about a clinical investigation for a medical device
  • See more

Conferences and events

  • Conferences and events
  • Request a MHRA speaker at an event or conference

Good practice, inspections and enforcement

  • Good manufacturing practice and good distribution practice
  • Good clinical practice for clinical trials
  • Guidance on qualified person responsible for pharmacovigilance (QPPV) including pharmacovigilance system master files (PSMF)
  • Good laboratory practice (GLP) for safety tests on chemicals
  • See more

Herbal and homeopathic medicines

  • Apply for a traditional herbal registration (THR)
  • MHRA fees
  • Herbal medicines granted a traditional herbal registration (THR)
  • Make a payment to MHRA
  • See more

Licensing

  • Medicines: reclassify your product

Manufacturing, wholesaling, importing and exporting medicines

  • Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients
  • Good manufacturing practice and good distribution practice
  • Medicines: reclassify your product
  • Medical devices: UK approved bodies
  • See more

Marketing authorisations, variations and licensing guidance

  • One-dose Janssen COVID-19 vaccine approved by the MHRA
  • Medicines: packaging, labelling and patient information leaflets
  • Medicines: reclassify your product
  • Innovative Licensing and Access Pathway
  • See more

Medical devices regulation and safety

  • Alerts, recalls and safety information: drugs and medical devices
  • Regulating medical devices in the UK
  • Register medical devices to place on the market
  • Medical devices: conformity assessment and the UKCA mark
  • See more

Scientific research and development

  • Innovative Licensing and Access Pathway (ILAP): New partner announcement
  • Prime Minister kicks off major new science initiative at visit of MHRA’s National Institute for Biological Standards and Control

Vigilance, safety alerts and guidance

  • Alerts, recalls and safety information: drugs and medical devices
  • Drug Safety Update
  • Coronavirus (COVID-19) vaccines adverse reactions
  • Medicines: packaging, labelling and patient information leaflets
  • See more

Is this page useful?

  • Maybe
Thank you for your feedback

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.

Help us improve GOV.UK

To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.

Topics

  • Benefits
  • Births, death, marriages and care
  • Business and self-employed
  • Childcare and parenting
  • Citizenship and living in the UK
  • Crime, justice and the law
  • Disabled people
  • Driving and transport
  • Education and learning
  • Employing people
  • Environment and countryside
  • Housing and local services
  • Money and tax
  • Passports, travel and living abroad
  • Visas and immigration
  • Working, jobs and pensions

Government activity

  • Departments
  • News
  • Guidance and regulation
  • Research and statistics
  • Policy papers and consultations
  • Transparency
  • How government works
  • Get involved

Support links

  • Help
  • Privacy
  • Cookies
  • Accessibility statement
  • Contact
  • Terms and conditions
  • Rhestr o Wasanaethau Cymraeg
  • Government Digital Service
All content is available under the Open Government Licence v3.0, except where otherwise stated
© Crown copyright